TNF and rheumatoid arthritis: In RA, many of the local and systemic manifestations appear to result from the production of a variety of cytokines within the inflamed synovium, particularly TNF-α, IL-1 and IL-6 [184], and inhibition of these cytokines with biologic agents is currently a main therapeutic option for patients with RA.